
    
      For the esophageal carcinoma in II~III stage, routine dosage of Paclitaxel and platinum
      medicine chemotherapy concurrently radical radiotherapy is worthy to be studied. On this
      base, we advanced approach the enlarged field radiotherapy and the intervention of Tarceva.
      And we approach the therapeutic effect for this method theoretically, which may give a
      further reasonable guidance for the clinical therapy.
    
  